tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
ARS Pharmaceuticals Gains Momentum: Buy Rating Justified by Market Share and Script Volume Increase
PremiumRatingsARS Pharmaceuticals Gains Momentum: Buy Rating Justified by Market Share and Script Volume Increase
1M ago
Raymond James positive on ARS Pharmaceuticals after weekly data
Premium
The Fly
Raymond James positive on ARS Pharmaceuticals after weekly data
1M ago
3 Best Stocks to Buy Now, 9/23/2025, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 9/23/2025, According to Top Analysts
1M ago
Roth starts ARS Pharmaceuticals at Buy, sees ‘vast improvement’ from Neffy
PremiumThe FlyRoth starts ARS Pharmaceuticals at Buy, sees ‘vast improvement’ from Neffy
2M ago
ARS Pharmaceuticals initiated with a Buy at Roth Capital
Premium
The Fly
ARS Pharmaceuticals initiated with a Buy at Roth Capital
2M ago
Short Report: C3.AI short positioning at 2025-high
Premium
The Fly
Short Report: C3.AI short positioning at 2025-high
2M ago
ARS Pharmaceuticals Reports Q2 2025 Financial Results
PremiumCompany AnnouncementsARS Pharmaceuticals Reports Q2 2025 Financial Results
3M ago
ARS Pharmaceuticals sees cash runway for at least next three years
Premium
The Fly
ARS Pharmaceuticals sees cash runway for at least next three years
3M ago
ARS Pharmaceuticals reports reports Q2 EPS (46c), consensus (51c)
Premium
The Fly
ARS Pharmaceuticals reports reports Q2 EPS (46c), consensus (51c)
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100